Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01447121 · ClinicalTrials.gov registry record · NA

User Study of an Investigational Blood Glucose Monitoring System

A NA study of Diabetes, sponsored by Ascensia Diabetes Care.

Completed
Registry status
NA
Development phase
118
Enrollment target
1
Study location

NCT01447121 is a NA study of Diabetes that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 118 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01447121, a NA study of Diabetes, has completed, sponsored by Ascensia Diabetes Care.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target
1
Study location

Study Summary

This clinical trial is designed to assess an investigational blood glucose monitoring system with fingerstick blood in the hands of untrained intended users.

Conditions Studied

Interventions

  • DEVICE Tatsu/Tradewind Investigational BG Monitoring System

Study Locations (1)

California

  • AMCR Institute - Escondido

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2011-09
Est. Completion 2011-09
Phase NA

Sponsor

Ascensia Diabetes Care

42 total trials

What the Registry Record Tells You About NCT01447121

The ClinicalTrials.gov registry entry for NCT01447121 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Tatsu/Tradewind Investigational BG Monitoring System is the first listed.

NCT01447121 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01447121 about?

NCT01447121 is a clinical study titled "User Study of an Investigational Blood Glucose Monitoring System". This clinical trial is designed to assess an investigational blood glucose monitoring system with fingerstick blood in the hands of untrained intended users.

What is the current status of trial NCT01447121?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2011-09. Estimated completion is 2011-09.

What conditions does trial NCT01447121 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01447121?

The interventions under investigation include: Tatsu/Tradewind Investigational BG Monitoring System (DEVICE).

Who is sponsoring clinical trial NCT01447121?

This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01447121 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.